Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Heinrich

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
The Lancet. Respiratory Medicine|July 19, 2025
endTB-Q results in the face of rising bedaquiline resistanceNorbert Heinrich, Norbert Ndjeka, Celso Khosa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 9, 2025
Corrigendum to "Candidate anti-tuberculosis medicines and regimens under clinical evaluation" [Clin Microbiol Infect 30(9) (2024) 1131-1138]Michael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 23, 2024
Candidate anti-tuberculosis medicines and regimens under clinical evaluationMichael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
The Journal of Infectious Diseases|November 13, 2023
A Systematic Review of Potential Biomarkers for Bacterial Burden and Treatment Efficacy Assessment in Tuberculosis Platform-Based Clinical TrialsJuan Espinosa-Pereiro, Riccardo Alagna, Francesca Saluzzo, et al.
The European Respiratory Journal|March 19, 2026
Rising bedaquiline resistance: exploring potential causes and next stepsJodie A Schildkraut, Debra Flood, Derek J Sloan, et al.
The Journal of Antimicrobial Chemotherapy|August 7, 2024
Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposuresKerstin Walter, Lindsey H M Te Brake, Ann-Kathrin Lemm, et al.
BMC Infectious Diseases|November 23, 2016
Drug resistance and population structure of M.tuberculosis isolates from prisons and communities in EthiopiaSolomon Ali, Patrick Beckert, Abraham Haileamlak, et al.
Health Security|February 3, 2016
Integrating Local, National, and International Stakeholders in Outbreak Preparedness in Developing Countries: Conclusions from a Conference in Mbeya, TanzaniaGuenter Froeschl, Nyanda Elias Ntinginya, Anthony Sangare, et al.
Plos Neglected Tropical Diseases|August 1, 2014
Seroprevalence of alphavirus antibodies in a cross-sectional study in southwestern Tanzania suggests endemic circulation of chikungunyaNina Weller, Petra Clowes, Gerhard Dobler, et al.
Plos Neglected Tropical Diseases|April 6, 2012
High seroprevalence of Rift Valley FEVER AND EVIDENCE FOR ENDEMIC circulation in Mbeya region, Tanzania, in a cross-sectional studyNorbert Heinrich, Elmar Saathoff, Nina Weller, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
The Lancet. Respiratory Medicine|July 19, 2025
endTB-Q results in the face of rising bedaquiline resistanceNorbert Heinrich, Norbert Ndjeka, Celso Khosa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 9, 2025
Corrigendum to "Candidate anti-tuberculosis medicines and regimens under clinical evaluation" [Clin Microbiol Infect 30(9) (2024) 1131-1138]Michael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 23, 2024
Candidate anti-tuberculosis medicines and regimens under clinical evaluationMichael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
The Journal of Infectious Diseases|November 13, 2023
A Systematic Review of Potential Biomarkers for Bacterial Burden and Treatment Efficacy Assessment in Tuberculosis Platform-Based Clinical TrialsJuan Espinosa-Pereiro, Riccardo Alagna, Francesca Saluzzo, et al.
The European Respiratory Journal|March 19, 2026
Rising bedaquiline resistance: exploring potential causes and next stepsJodie A Schildkraut, Debra Flood, Derek J Sloan, et al.
The Journal of Antimicrobial Chemotherapy|August 7, 2024
Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposuresKerstin Walter, Lindsey H M Te Brake, Ann-Kathrin Lemm, et al.
BMC Infectious Diseases|November 23, 2016
Drug resistance and population structure of M.tuberculosis isolates from prisons and communities in EthiopiaSolomon Ali, Patrick Beckert, Abraham Haileamlak, et al.
Health Security|February 3, 2016
Integrating Local, National, and International Stakeholders in Outbreak Preparedness in Developing Countries: Conclusions from a Conference in Mbeya, TanzaniaGuenter Froeschl, Nyanda Elias Ntinginya, Anthony Sangare, et al.
Plos Neglected Tropical Diseases|August 1, 2014
Seroprevalence of alphavirus antibodies in a cross-sectional study in southwestern Tanzania suggests endemic circulation of chikungunyaNina Weller, Petra Clowes, Gerhard Dobler, et al.
Plos Neglected Tropical Diseases|April 6, 2012
High seroprevalence of Rift Valley FEVER AND EVIDENCE FOR ENDEMIC circulation in Mbeya region, Tanzania, in a cross-sectional studyNorbert Heinrich, Elmar Saathoff, Nina Weller, et al.
Pageof 9